Search Results for "Healthcare and Medical Market Insights"

About the Healthcare and Medical Industry

The global healthcare and medical industry is a vast and diverse industry, encompassing a huge number of separate and distinct subsectors and ancillary services and products. From medical equipment to pharmaceuticals, from medical tourism to health insurance, the healthcare and medical market comprises a growing and diverse sector.

It is esimated that global healthcare expenditure is valued at some $5.6 trillion, which represents approximately 10% of global GDP. There are marked differences in healthcare spending when analysed geographically. Per capita healthcare expenditure is much higher in western economies than in emerging economies. North America accounts for around 50% of total global healthcare expenditure.

It is estimated that the global pharmaceuticals market is estimated by valued at around $1.6 trillion, growing at an annual rate of around 4% to 6% per year. The global healthcare equipment and supplies market is worth at approximately $500 billion, with disposable supplies accounting for some 40% of the value. Analysed geographically, Americas accounts for nearly half of the healthcare equipment and supplies market, with Europe at around 30%.

Healthcare and Medical Market Snapshot Data (selected)

Healthcare BPO Market

The global healthcare BPO market is growing at a healthy CAGR of 21.4%. Pharmaceutical outsourcing accounts for the largest share of 64.3%, but will grow at a CAGR of 14.6% from 2011 to 2016 since the market is saturated. The major players in the payer and provider outsourcing market are Accenture (Ireland), Medusind (U.S.), GeBBS Healthcare (U.S.), Omega Healthcare (India), and Inventive (U.S.). The pharmaceutical outsourcing market is captured by players such as Quintiles (U.S.), Covance (U.S.), PPD (U.S.), Parexel (U.S.), Charles Rivers Laboratories (U.S.) and ICON (Ireland) in the CRO space; while in the CMO market the major competitors are Lonza (Switzerland), Catalent (U.S.), Boehringer Ingelheim (Germany), DSM Pharma (U.S.), and Jubilant Life Sciences (India).

Global Influenza Vaccine Market

The global influenza vaccine market has experienced phenomenal growth in recent years at a compound annual growth rate of more than 65% between 2008 and 2010. This growth was mainly driven by the global spread of H1N1 influenza. But in the year 2011 H1N1 pandemic flu vaccine market declined due to waning threat of swine flu disease. However seasonal influenza vaccine market is predicted to grow year on year and cross US$ 4 Billion by 2015.

Global Pharmaceutical Market

By 2016, the global pharmaceutical market, including pharmacy and hospital sales, is forecast to be worth around US$1.6 trillion at retail prices. High growth in emerging markets will leverage slow growth in developed markets. Cost-containment policies will be offset against market demands for more effective products. Health access will expand, due to increasing generic penetration.

Global Biotechnology Market

The global market for sample preparation reagents and products used in life science research was $2.9 billion in 2010 and is expected to increase to $3.6 billion by 2011. The market is forecast to reach $8.4 billion by 2016, increasing at a compound annual growth rate (CAGR) of 18.8%. The global biobanking market was $141 billion in 2010 and is projected to expand by 30% between 2010 and 2015, increasing at a CAGR of 5.4%. The global RNAi drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015, increasing at a five-year CAGR of 27.9%.

Global Biopsy Devices Market

Analysts forecast the Global Biopsy Devices market to reach US$1193.3 million by 2014. One of the key factors contributing to this market growth is the increase in cancer patients worldwide. The Global Biopsy Devices market has also been witnessing the usage of vacuum-assisted biopsy devices. However, the lack of reimbursement for screenings could be a challenge to the growth of this market.

Global Endoscopy Market

The Global Endoscopy market is set to reach US$30.1 billion by 2014. One of the key factors contributing to this market growth is the increase in the ageing and chronically ill population worldwide. The Global Endoscopy market has also been witnessing the rise in the popularity of minimally invasive surgery. However, the high cost of endoscopic equipment could be a challenge to the growth of this market.

Global Active Pharmaceutical Ingredient Market

The Active Pharmaceutical Ingredient (API) forms the most vital part of every formulated end product, and is an important part of the whole pharmaceutical industry. The overall API market was valued at $101.08 billion in 2010, and is expected to grow at a CAGR of 7.9% from 2011 to 2016.

For more Healthcare and Medical reports, please see our Healthcare and Medical Market Research list of reports.